Literature DB >> 24789798

Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4.

Valéria Szijártó1, Jolanta Lukasiewicz2, Tomasz K Gozdziewicz2, Zoltán Magyarics1, Eszter Nagy1, Gábor Nagy3.   

Abstract

The Escherichia coli lineage sequence type 131 (ST131)-O25b:H4 is a globally spread multidrug-resistant clone responsible for a great proportion of extraintestinal infections. Driven by the significant medical needs associated with this successful pathogenic lineage, we generated murine monoclonal antibodies (MAbs) against its lipopolysaccharide (LPS) O25b antigen in order to develop quick diagnostic tests. Murine monoclonal antibodies were generated by immunizing mice with whole killed nonencapsulated ST131-O25b E. coli cells and screening hybridoma supernatants for binding to purified LPS molecules obtained from an E. coli ST131-O25b clinical isolate. The MAbs selected for further study bound to the surface of live E. coli O25b strains irrespective of the capsular type expressed, while they did not bind to bacteria or purified LPS from other serotypes, including the related classical O25 antigen (O25a). Using these specific MAbs, we developed a latex bead-based agglutination assay that has greater specificity and is quicker and simpler than the currently available typing methods. The high specificities of these MAbs can be explained by the novel structure of the O25b repeating unit elucidated in this article. Based on comparative analysis by nuclear magnetic resonance (NMR) and mass spectrometry, the N-acetyl-fucose in the O25a O-antigen had been replaced by O-acetyl-rhamnose in the O25b repeating unit. The genetic determinants responsible for this structural variation were identified by aligning the corresponding genetic loci and were confirmed by trans-complementation of a rough mutant by the subserotype-specific fragments of the rfb operons.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789798      PMCID: PMC4097449          DOI: 10.1128/CVI.00685-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  31 in total

1.  Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.

Authors:  Aránzazu Valverde; Teresa M Coque; M Paz Sánchez-Moreno; Azucena Rollán; Fernando Baquero; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  A comparison of immunoblotting, flow cytometry and ELISA to monitor the binding of anti-lipopolysaccharide monoclonal antibodies.

Authors:  D Nelson; W Neill; I R Poxton
Journal:  J Immunol Methods       Date:  1990-10-19       Impact factor: 2.303

3.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia.

Authors:  Olivier Clermont; James R Johnson; Megan Menard; Erick Denamur
Journal:  Diagn Microbiol Infect Dis       Date:  2006-10-03       Impact factor: 2.803

5.  Structural studies of the Escherichia coli O-antigen 25.

Authors:  L Kenne; B Lindberg; J K Madden; A A Lindberg; P Gemski
Journal:  Carbohydr Res       Date:  1983-10-28       Impact factor: 2.104

Review 6.  The structures of Escherichia coli O-polysaccharide antigens.

Authors:  Roland Stenutz; Andrej Weintraub; Göran Widmalm
Journal:  FEMS Microbiol Rev       Date:  2006-05       Impact factor: 16.408

7.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

Authors:  Marie-Hélène Nicolas-Chanoine; Jorge Blanco; Véronique Leflon-Guibout; Raphael Demarty; Maria Pilar Alonso; Maria Manuela Caniça; Yeon-Joon Park; Jean-Philippe Lavigne; Johann Pitout; James R Johnson
Journal:  J Antimicrob Chemother       Date:  2007-12-11       Impact factor: 5.790

8.  Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.

Authors:  Olivier Clermont; Hiran Dhanji; Mathew Upton; Tarek Gibreel; Andrew Fox; David Boyd; Michael R Mulvey; Patrice Nordmann; Etienne Ruppé; Jean Louis Sarthou; Thierry Frank; Sophie Vimont; Guillaume Arlet; Catherine Branger; Neil Woodford; Erick Denamur
Journal:  J Antimicrob Chemother       Date:  2009-05-27       Impact factor: 5.790

9.  Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.

Authors:  Bente Olesen; Dennis S Hansen; Frida Nilsson; Jakob Frimodt-Møller; Rikke Fleron Leihof; Carsten Struve; Flemming Scheutz; Brian Johnston; Karen A Krogfelt; James R Johnson
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

10.  GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans.

Authors:  Alessio Ceroni; Kai Maass; Hildegard Geyer; Rudolf Geyer; Anne Dell; Stuart M Haslam
Journal:  J Proteome Res       Date:  2008-03-01       Impact factor: 4.466

View more
  15 in total

1.  Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.

Authors:  Valéria Szijártó; Luis M Guachalla; Zehra C Visram; Katharina Hartl; Cecília Varga; Irina Mirkina; Jakub Zmajkovic; Adriana Badarau; Gerhild Zauner; Clara Pleban; Zoltán Magyarics; Eszter Nagy; Gábor Nagy
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

2.  Discovery of monoclonal antibodies cross-reactive to novel subserotypes of K. pneumoniae O3.

Authors:  Luis M Guachalla; Katarina Stojkovic; Katharina Hartl; Marta Kaszowska; Yadhu Kumar; Benjamin Wahl; Tobias Paprotka; Eszter Nagy; Jolanta Lukasiewicz; Gábor Nagy; Valéria Szijártó
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

3.  Multiple Modes of Action of a Monoclonal Antibody against Multidrug-Resistant Escherichia coli Sequence Type 131-H30.

Authors:  Luis M Guachalla; Katharina Hartl; Cecília Varga; Lukas Stulik; Irina Mirkina; Stefan Malafa; Eszter Nagy; Gábor Nagy; Valéria Szijártó
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  Route of infection alters virulence of neonatal septicemia Escherichia coli clinical isolates.

Authors:  Bryan K Cole; Edgar Scott; Marko Ilikj; David Bard; Darrin R Akins; David W Dyer; Susana Chavez-Bueno
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.752

5.  Outer Membrane Proteome of Veillonella parvula: A Diderm Firmicute of the Human Microbiome.

Authors:  Daniel I Poppleton; Magalie Duchateau; Véronique Hourdel; Mariette Matondo; Jennifer Flechsler; Andreas Klingl; Christophe Beloin; Simonetta Gribaldo
Journal:  Front Microbiol       Date:  2017-06-30       Impact factor: 5.640

6.  Identification of d-Galactan-III As Part of the Lipopolysaccharide of Klebsiella pneumoniae Serotype O1.

Authors:  Katarina Stojkovic; Valéria Szijártó; Marta Kaszowska; Tomasz Niedziela; Katharina Hartl; Gábor Nagy; Jolanta Lukasiewicz
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

7.  Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain.

Authors:  Luis M Guachalla; Katharina Ramoni; Cecilia Varga; Michele Mutti; Akela Ghazawi; Tibor Pál; Eszter Nagy; Ágnes Sonnevend; Gábor Nagy; Valéria Szijártó
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

8.  The development and characterization of an E. coli O25B bioconjugate vaccine.

Authors:  Michael Kowarik; Michael Wetter; Micha A Haeuptle; Martin Braun; Michael Steffen; Stefan Kemmler; Neil Ravenscroft; Gianluigi De Benedetto; Matthias Zuppiger; Dominique Sirena; Paola Cescutti; Michael Wacker
Journal:  Glycoconj J       Date:  2021-03-17       Impact factor: 2.916

9.  Complete Genome Sequence of Escherichia coli 81009, a Representative of the Sequence Type 131 C1-M27 Clade with a Multidrug-Resistant Phenotype.

Authors:  Michele Mutti; Ágnes Sonnevend; Tibor Pál; Sini Junttila; Heinz Ekker; Bence Galik; Attila Gyenesei; Gábor Nagy; Eszter Nagy; Valéria Szijártó
Journal:  Genome Announc       Date:  2018-02-22

10.  A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups.

Authors:  Daniela S Castillo; Diego A Rey Serantes; Luciano J Melli; Andrés E Ciocchini; Juan E Ugalde; Diego J Comerci; Alejandro Cassola
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.